Medical equipment data
Health topic HIV/AIDS
Health classification Treatment
Project data
Location California, United States
Status Clinical trial
Made No
Replicated No
OKH Manifest Open Know-How Manifest Download

"Clinical trial" is not in the list (Idea, Designed, Modelled, Prototyped, Verified, Deployed, Commercialized) of allowed values for the "Status" property.

Problem being addressed[edit | edit source]

The Hemopurifier™ has been developed to address the treatment of drug and vaccine-resistant pathogens, including Ebola & HIV which causes AIDS.

Detailed description of the solution[edit | edit source]

The Hemopurifier™ is a dialysis-type medical device designed to mimic the natural immune response of clearing infectious viruses and toxins before the occurrence of cell and organ infection. Human in-vitro blood studies have documented a rapid capture of circulating HIV and gp120, a toxic surface protein known to deplete the immune T-cells required to fight off infection. If commercialized, the Hemopurifier™ would represent the first medical device enlisted as a treatment for HIV/AIDS.

Designed by[edit | edit source]

  • Design: Aethlon Medical, Inc.
  • Manufacturer Location: San Diego, California, USA

When and where it was tested/implemented[edit | edit source]

Testing has been done in the United States since 2001. It is currently being tested in human clinical trials in India.

Funding Source[edit | edit source]

Private Funding

References[edit | edit source]

Peer-reviewed publication[edit | edit source]

Duffin, R.P. & Tullis, R.H. (2002). Mathematical models that predict the complete course of HIV infection and AIDS. J. Theor. Med, 4(3), 157-166.

Tullis, R.H., Ambrus, J.L. & Joyce, J.A. (2001). Affinity Hemodialysis as a Treatment for AIDS. American Clinical Laboratories, Oct/Nov, 22-23.

Tullis, R.H., Duffin, R.P., Zech, M. & Ambrus, J.L. (2001). Affinity Hemodialysis for Antiviral Therapy. I. Removal of HIV-1 from Cell Culture Supernatants, Plasma and Blood. Therapeutic Apheresis, 6 (3), 213-220.

Tullis, R.H., Scammura, D.O. & Ambrus, J.L. (2002). Affinity Hemodialysis for Antiviral Therapy with Specific Application to HIV. J. Theor Med, 3(2002), 157-166.

Tullis, R.H., Duffin, R.P., Zech, M. & Ambrus, J.L. (2003). Affinity hemodialysis for antiviral therapy. II. Removal of HIV-1 viral proteins from cell culture supernatants and whole blood. Blood Purification, 21(1), 58-64.

Approval by regulatory bodies or standards boards[edit | edit source]

An investigational device exemption (IDE) to initiate clinical studies in the United States is pending with the Food and Drug Administration.

Page data
Part of Global Health Medical Device Compendium
Type Medical equipment, Project
SDG Sustainable Development Goal SDG03 Good health and well-being, SDG09 Industry innovation and infrastructure
Published 2012
License CC-BY-SA-3.0
Language English (en)
Impact Number of views to this page and its redirects. Updated once a month. Views by admins and bots are not counted. Multiple views during the same session are counted as one. 517
Issues Automatically detected page issues. Click on them to find out more. They may take some minutes to disappear after you fix them. No main image
Cookies help us deliver our services. By using our services, you agree to our use of cookies.